Nanomedicine for intra-articular drug delivery in rheumatoid arthritis

Hannah O'Mary, Inmaculada Del Rincón, Zhengrong Cui

Producción científica: Review articlerevisión exhaustiva

17 Citas (Scopus)


Rheumatoid arthritis is characterized by chronic inflammation within the joint. Recent developments in the understanding of inflammation have led to an increased interest in the use of nanomedicine in the treatment and diagnosis of rheumatoid arthritis. The ability of nanomedicine, such as nanoparticles, to permeate into and/or retain within the inflamed joint after intravenous and/or intra-articular administration has proven to be beneficial in improving rheumatoid arthritis therapy while reducing systemic exposure of patients to potentially toxic anti-arthritic drugs. This review aims at explaining the major applications of nanomedicine in rheumatoid arthritis treatment and diagnosis.

Idioma originalEnglish (US)
Páginas (desde-hasta)2490-2506
Número de páginas17
PublicaciónCurrent Medicinal Chemistry
EstadoPublished - jul 1 2016

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry


Profundice en los temas de investigación de 'Nanomedicine for intra-articular drug delivery in rheumatoid arthritis'. En conjunto forman una huella única.

Citar esto